Showing results (951-960 of 1,073) with videos related to

Sort By:
Pageof 108
The Review of Scientific Instruments|July 3, 2016
A liquid jet setup for x-ray scattering experiments on complex liquids at free-electron laser sourcesI Steinke, M Walther, F Lehmkühler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemiaRebecca B Klisovic, Wendy Stock, Spero Cataland, et al.
British Journal of Cancer|January 8, 2004
Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemiaN Jourdan-Da Silva, Y Perel, F Méchinaud, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantationJames A Russell, Shahbal B Kangarloo, Tyler Williamson, et al.
Cancer Research|March 20, 2019
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1<sup>-</sup>HK2<sup>+</sup> Multiple MyelomaShili Xu, Tianyuan Zhou, Hanna M Doh, et al.
Mabs|April 4, 2022
In silico proof of principle of machine learning-based antibody design at unconstrained scaleRahmad Akbar, Philippe A Robert, Cédric R Weber, et al.
Science Translational Medicine|June 16, 2017
Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRASSarah J Ross, Alexey S Revenko, Lyndsey L Hanson, et al.
Leukemia|September 24, 2010
NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951E Clappier, S Collette, N Grardel, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitorsArkadii Vaisburg, Naomy Bernstein, Sylvie Frechette, et al.
Leukemia|January 28, 2005
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemiasF Speleman, B Cauwelier, N Dastugue, et al.
Pageof 108